| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |